Pattern of microstructural brain tissue alterations in Fabry disease: A diffusion-tensor imaging study

Journal of Neurology

Volumn 253, Issue 6, 2006, Pages 780-787

  Fellgiebel, A ^a   Mazanek, M ^b   Whybra, C ^b   Beck, M ^b   Hartung, R ^b   Muller K M ^a   Scheurich, A ^a   Dellani, P R ^b   Stoeter, P ^b   Muller M J ^a  

^a UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Diffusion tensor imaging; DTI; Fabry disease

Indexed keywords

ADULT; ANISOTROPY; ARTICLE; BRAIN; CEREBROVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST; DIFFUSION TENSOR IMAGING; ENZYME REPLACEMENT; FABRY DISEASE; FEMALE; HIPPOCAMPUS; HUMAN; LYSOSOME STORAGE DISEASE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; THALAMUS; WHITE MATTER;

ADULT; BRAIN; BRAIN MAPPING; CASE-CONTROL STUDIES; DIFFUSION MAGNETIC RESONANCE IMAGING; FABRY DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEURONAL PLASTICITY; SEX FACTORS;

EID: 33745571225     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-006-0118-y     Document Type: Article

References (30)

1. Meikle PJ, Hopwood JJ, Clague AE, Carey WF (1999) Prevalence of lysosomal storage disorders. JAMA 281:249-254
2. Davies JP, Eng CM, Hill JA, Malcolm S, MacDermot K, Winchester B, Desnick RJ (1996) Fabry disease: fourteen alpha-galactosidase A mutations in unrelated families from the United Kingdom and other European countries. Eur J Hum Genet 4:219-224
3. Mitsias P, Levine SR (1996) Cerebrovascular complications of Fabry's disease. Ann Neurol 40:8-17
4. MacDermot KD, Holmes A, Miners AH (2001) Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous males. J Med Genet 38:750-760
5. Mehta A, Ricci R, Widmer U, Dehout F, Garcia De Lorenzo A, Kampmann C, Linhart A, Sunder-Plassmann G, Ries M, Beck M (2004) Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey. Eur J Clin Invest 34:236-242
6. Hilz MJ, Kolodny EH, Brys M, Stemper B, Haendl T, Marthol H (2004) Reduced cerebral blood flow velocity and impaired cerebral autoregulation in patients with Fabry disease. J Neurol 251:564-570
7. Moore DF, Scott LT, Gladwin MT, Altarescu G, Kaneski C, Suzuki K, Pease-Fye M, Ferri R, Brady RO, Herscovitch P, Schiffmann R (2001) Regional cerebral hyperperfusion and nitric oxide pathway dysregulation in Fabry disease: reversal by enzyme replacement therapy. Circulation 104:1506-1512
8. Whybra C, Kampmann C, Willers I, Davies J, Winchester B, Kriegsmann J, Bruhl K, Gal A, Bunge S, Beck M (2001) Anderson-Fabry disease: clinical manifestations of disease in female heterozygotes. J Inherit Metab Dis 24:715-724
9. MacDermot KD, Holmes A, Miners AH (2001) Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females. J Med Genet 38:769-775
10. Crutchfield KE, Patronas NJ, Dambrosia JM, Frei KP, Banerjee TK, Barton NW, Schiffmann R (1998) Quantitative analysis of cerebral vasculopathy in patients with Fabry disease. Neurology 50:1746-1749
11. Moore DF, Herscovitch P, Schiffmann R (2001) Selective arterial distribution of cerebral hyperperfusion in Fabry disease. J Neuroimaging 11:303-307
12. Kolodny EH, Pastores GM (2002) Anderson-Fabry disease: extrarenal, neurologic manifestations. J Am Soc Nephrol 13(Suppl 2):S150-S153
13. Fellgiebel A MM, Mazanek M, Baron K, Beck M, Stoeter P (2005) White matter lesions severity in male and female patients with Fabry disease. Neurology (in press)
14. Pantoni L, Garcia JH (1997) Pathogenesis of leukoaraiosis: a review. Stroke 28:652-659
15. Prins ND, van Straaten EC, van Dijk EJ, Simoni M, van Schijndel RA, Vrooman HA, Koudstaal PJ, Scheltens P, Breteler MM, Barkhof F (2004) Measuring progression of cerebral white matter lesions on MRI: visual rating and volumetrics. Neurology 62:1533-1539
16. Le Bihan D, Mangin JF, Poupon C, Clark CA, Pappata S, Molko N, Chabriat H (2001) Diffusion tensor imaging: concepts and applications. J Magn Reson Imaging 13:534-546
17. Taylor WD, Hsu E, Krishnan KR, MacFall JR (2004) Diffusion tensor imaging: background, potential, and utility in psychiatric research. Biol Psychiatry 55:201-207
18. Hubl D, Koenig T, Strik W, Federspiel A, Kreis R, Boesch C, Maier SE, Schroth G, Lovblad K, Dierks T (2004) Pathways that make voices: white matter changes in auditory hallucinations. Arch Gen Psychiatry 61:658-668
19. Fellgiebel A, Wille P, Muller MJ, Winterer G, Scheurich A, Vucurevic G, Schmidt LG, Stoeter P (2004) Ultrastructural hippocampal and white matter alterations in mild cognitive impairment: a diffusion tensor imaging study. Dement Geriatr Cogn Disord 18:101-108
20. Sach M, Winkler G, Glauche V, Liepert J, Heimbach B, Koch MA, Buchel C, Weiller C (2004) Diffusion tensor MRI of early upper motor neuron involvement in amyotrophic lateral sclerosis. Brain 127:340-350
21. Pfefferbaum A, Sullivan EV (2002) Microstructural but not macrostructural disruption of white matter in women with chronic alcoholism. Neuroimage 15:708-718
22. Desnick RJ, Brady R, Barranger J, Collins AJ, Germain DP, Goldman M, Grabowski G, Packman S, Wilcox WR (2003) Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy. Ann Intern Med 138:338-346
23. Basser PJ, Mattiello J, LeBihan D (1994) Estimation of the effective self-diffusion tensor from the NMR spin echo. J Magn Reson B 103:247-254
24. O'Sullivan M, Summers PE, Jones DK, Jarosz JM, Williams SC, Markus HS (2001) Normal-appearing white matter in ischemic leukoaraiosis: a diffusion tensor MRI study. Neurology 57:2307-2310
25. Moore DF, Schiffmann R, Ulug AM (2002) Elevated CNS average diffusion constant in Fabry disease. Acta Paediatr Suppl 91:S67-S68
26. O'Sullivan M, Morris RG, Huckstep B, Jones DK, Williams SC, Markus HS (2004) Diffusion tensor MRI correlates with executive dysfunction in patients with ischaemic leukoaraiosis. J Neurol Neurosurg Psychiatry 75:441-447
27. Fellgiebel A, Muller MJ, Mazanek M, Baron K, Beck M, Stoeter P (2005) White matter lesion severity in male and female patients with Fabry disease. Neurology 65:600-602
28. Barkhof F, Scheltens P (2002) Imaging of white matter lesions. Cerebrovasc Dis 13(Suppl 2):S21-S30
29. Chabriat H, Pappata S, Poupon C, Clark CA, Vahedi K, Poupon F, Mangin JF, Pachot-Clouard M, Jobert A, Le Bihan D, Bousser MG (1999) Clinical severity in CADASIL related to ultrastructural damage in white matter: in vivo study with diffusion tensor MRI. Stroke 30:2637-2643
30. Holtmannspotter M, Peters N, Opherk C, Martin D, Herzog J, Bruckmann H, Samann P, Gschwendtner A, Dichgans M (2005) Diffusion Magnetic Resonance Histograms as a Surrogate Marker and Predictor of Disease Progression in CADASIL. A Two-Year Follow-Up Study. Stroke